Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune response to hepatitis B challenge dose about 6 years after primary Engerix-B vaccination
2007-000261-38Phase 4Completed
- Sponsor
- GSK
- Start
- Jul 2007
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Hepatitis B vaccine in hepatitis B (HBV), sponsored by GSK. Primary endpoint: Immune response to a hepatitis B vaccine challenge dose. Started Jul 2007; status: completed.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on 2007-000261-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000261-38.